{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:30:51Z","timestamp":1793039451758,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Impaired kidney function is often associated with acute decompensation of chronic heart failure and portends a poor prognosis. Unfortunately, current data have demonstrated worse survival in patients with acute kidney injury than in patients with chronic kidney disease during durable\u00a0LVAD placement as  bridge therapy. Furthermore, end-stage heart failure patients undergoing combined heart-kidney transplantation have poorer short- and long-term survival than heart transplants alone. We evaluated the kidney function recovery in our heart failure population awaiting heart transplantation at our institution, supported by temporary Mechanical Circulatory Support (tMCS)\u00a0with Impella 5.5. The protocol (#22004000) was approved by the Mayo Clinic institutional review board, after which we performed a retrospective review of all patients with acute on chronic heart failure and kidney disease in patients considered for only heart and kidney combined organ transplant and supported by tMCS between January 2020 and February 2021. Hemodynamic and kidney function trends were recorded and analyzed before and after tMCS placement and transplantation. After placement of tMCS, we observed a trend towards improvement in creatinine, Fick cardiac index, mixed venous saturation, and glomerular filtration rate (GFR), which persisted through transplantation and discharge. The average duration of support with tMCS was 16.5\u00a0days before organ transplantation. The median pre-tMCS creatinine was 2.1\u00a0mg\/dL (IQR 1.75\u20132.3). Median hematocrit at the time of tMCS placement was 32% (IQR 32\u201334), and the median estimated glomerular filtration rate was 34\u00a0mL\/min\/BSA (34\u201340). The median GFR improved to 44\u00a0mL\/min\/BSA (IQR 45\u201351), and serum creatinine improved to 1.5\u00a0mg\/dL (1.5\u20131.8) after tMCS. Median discharge creatinine was 1.1\u00a0mg\/dL (1.19\u20131.25) with a GFR of 72 (65\u201374). None of these six patients supported with tMCS required renal replacement therapy after heart transplantation. Early adoption of Impella 5.5 in this patient population resulted in renal recovery without needing renal replacement therapies or dual organ transplantation and should be further evaluated.<\/jats:p>","DOI":"10.1038\/s41598-023-46901-7","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T06:01:39Z","timestamp":1699682499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Axillary mechanical circulatory support improves renal function prior to heart transplantation in patients with chronic kidney disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Ji-Min","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tambi","family":"Jarmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basar","family":"Sareyyupoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Nativi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Landolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan M.","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,11]]},"reference":[{"issue":"4","key":"46901_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s11897-018-0397-5","volume":"15","author":"A Bielecka-Dabrowa","year":"2018","unstructured":"Bielecka-Dabrowa, A. et al. Decompensated heart failure and renal failure: What is the current evidence?\u201d. Curr. Heart Fail. Rep. 15(4), 224\u2013238. https:\/\/doi.org\/10.1007\/s11897-018-0397-5 (2018).","journal-title":"Curr. Heart Fail. Rep."},{"key":"46901_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/icvts\/ivab357","volume":"44","author":"HK Lamba","year":"2021","unstructured":"Lamba, H. K. et al. The influence of preoperative dialysis on survival after continuous-flow left ventricular assist device implantation. Interact. Cardiovasc. Thorac. Surg. 44, 470\u2013477. https:\/\/doi.org\/10.1093\/icvts\/ivab357 (2021).","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"46901_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jcrc.2019.11.001","volume":"55","author":"V Keleshian","year":"2020","unstructured":"Keleshian, V. et al. Short, and long-term mortality among cardiac intensive care unit patients started on continuous renal replacement therapy. J. Crit. Care 55, 64\u201372. https:\/\/doi.org\/10.1016\/j.jcrc.2019.11.001 (2020).","journal-title":"J. Crit. Care"},{"issue":"5","key":"46901_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.14740\/jocmr4449","volume":"13","author":"VD Upadhyaya","year":"2021","unstructured":"Upadhyaya, V. D. et al. Outcomes of renal function in cardiogenic shock patients with or without mechanical circulatory support. J. Clin. Med. Res. 13(5), 283\u2013292. https:\/\/doi.org\/10.14740\/jocmr4449 (2021).","journal-title":"J. Clin. Med. Res."},{"issue":"4","key":"46901_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1600-6143.2009.02588.x","volume":"9","author":"J Gill","year":"2009","unstructured":"Gill, J. et al. Outcomes of simultaneous heart-kidney transplant in the US: A retrospective analysis using OPTN\/UNOS data. Am. J. Transplant. 9(4), 844\u2013852. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02588.x (2009).","journal-title":"Am. J. Transplant."},{"issue":"3","key":"46901_CR6","doi-asserted-by":"publisher","first-page":"e0212352","DOI":"10.1371\/journal.pone.0212352","volume":"14","author":"S-W Chen","year":"2019","unstructured":"Chen, S.-W. et al. Long-term outcomes after extracorporeal membrane oxygenation in patients with dialysis-requiring acute kidney injury: A cohort study. PLoS ONE 14(3), e0212352. https:\/\/doi.org\/10.1371\/journal.pone.0212352 (2019).","journal-title":"PLoS ONE"},{"issue":"2","key":"46901_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1001\/jamainternmed.2017.4831","volume":"178","author":"N Bansal","year":"2018","unstructured":"Bansal, N. et al. Outcomes associated with left ventricular assist devices among recipients with and without end-stage renal disease. JAMA Intern. Med. 178(2), 204\u2013209. https:\/\/doi.org\/10.1001\/jamainternmed.2017.4831 (2018).","journal-title":"JAMA Intern. Med."},{"issue":"12","key":"46901_CR8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/01.cir.0000159340.93220.e4","volume":"111","author":"JD Sackner-Bernstein","year":"2005","unstructured":"Sackner-Bernstein, J. D. et al. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111(12), 1487\u20131491. https:\/\/doi.org\/10.1161\/01.cir.0000159340.93220.e4 (2005).","journal-title":"Circulation"},{"issue":"8","key":"46901_CR9","doi-asserted-by":"publisher","first-page":"6971","DOI":"10.1161\/circheartfailure.120.006971","volume":"13","author":"LV Huckaby","year":"2020","unstructured":"Huckaby, L. V. et al. Intra-aortic balloon pump bridging to heart transplantation. Circulation 13(8), 6971. https:\/\/doi.org\/10.1161\/circheartfailure.120.006971 (2020).","journal-title":"Circulation"},{"key":"46901_CR10","doi-asserted-by":"crossref","unstructured":"Sarraf, M., Masoumi, A., & Schrier, R. W. Cardiorenal Syndrome in Acute Decompensated Heart Failure (American Society of Nephrology, 2009). Retrieved January 27, 2022, from https:\/\/cjasn.asnjournals.org\/content\/4\/12\/2013.","DOI":"10.2215\/CJN.03150509"},{"issue":"3","key":"46901_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ccl.2019.04.001","volume":"37","author":"U Kumar","year":"2019","unstructured":"Kumar, U., Wettersten, N. & Garimella, P. S. Cardiorenal syndrome: Pathophysiology. Cardiol. Clin. 37(3), 251\u2013265. https:\/\/doi.org\/10.1016\/j.ccl.2019.04.001 (2019).","journal-title":"Cardiol. Clin."},{"issue":"2","key":"46901_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1113\/expphysiol.1997.sp004024","volume":"82","author":"H Sies","year":"1997","unstructured":"Sies, H. Oxidative stress: Oxidants and antioxidants. Exp Physiol. 82(2), 291\u2013295. https:\/\/doi.org\/10.1113\/expphysiol.1997.sp004024 (1997).","journal-title":"Exp Physiol."},{"key":"46901_CR13","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1161\/01.HYP.0000163462.98381.7f","volume":"45","author":"S Kimura","year":"2005","unstructured":"Kimura, S. et al. Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 45, 860\u2013866 (2005).","journal-title":"Hypertension"},{"key":"46901_CR14","first-page":"573","volume-title":"Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine","author":"KD Aaronson","year":"2019","unstructured":"Aaronson, K. D. & Pagani, F. D. Temporary mechanical circulatory support. In Braunwald\u2019s Heart Disease: A Textbook of Cardiovascular Medicine 11th edn (ed. Zipes, D. P.) 573\u2013575 (Elsevier, 2019).","edition":"11"},{"key":"46901_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/cc13180","volume":"18","author":"SL Goldstein","year":"2014","unstructured":"Goldstein, S. L. et al. Renal recovery. Crit. Care 18, 301. https:\/\/doi.org\/10.1186\/cc13180 (2014).","journal-title":"Crit. Care"},{"key":"46901_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2215\/CJN.12101112","volume":"8","author":"SL Goldstein","year":"2013","unstructured":"Goldstein, S. L., Jaber, B. L., Faubel, S. & Chawla, L. S. Acute kidney injury advisory group of American Society of Nephrology: AKI transition of care: A potential opportunity to detect and prevent CKD. Clin. J. Am. Soc. Nephrol. 8, 476\u2013483. https:\/\/doi.org\/10.2215\/CJN.12101112 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"46901_CR17","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","volume":"51","author":"A Nohria","year":"2008","unstructured":"Nohria, A. et al. Cardiorenal interactions: Insights from the ESCAPE trial. J. Am. Coll. Cardiol. 51, 1268\u20131274. https:\/\/doi.org\/10.1016\/j.jacc.2007.08.072 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"46901_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","volume":"53","author":"K Damman","year":"2009","unstructured":"Damman, K. et al. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J. Am. Coll. Cardiol. 53, 582\u2013588. https:\/\/doi.org\/10.1016\/j.jacc.2008.08.080 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"46901_CR19","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami, J. et al. Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the American Heart Association. Circulation 139(16), e840\u2013e878. https:\/\/doi.org\/10.1161\/CIR.0000000000000664 (2019).","journal-title":"Circulation"},{"issue":"2","key":"46901_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccl.2020.01.004","volume":"38","author":"T Tabucanon","year":"2020","unstructured":"Tabucanon, T. & Tang, W. H. W. Right heart failure and cardiorenal syndrome. Cardiol. Clin. 38(2), 185\u2013202. https:\/\/doi.org\/10.1016\/j.ccl.2020.01.004 (2020).","journal-title":"Cardiol. Clin."},{"key":"46901_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008664","volume":"7","author":"CP Walther","year":"2018","unstructured":"Walther, C. P. et al. Implantable ventricular assist device use and outcomes in people with end-stage renal disease. J. Am. Heart Assoc. 7, e008664. https:\/\/doi.org\/10.1161\/JAHA.118.008664 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"46901_CR22","first-page":"1","volume-title":"Decision Memo for Artificial Hearts and Related Devices, Including Ventricular Assist Devices for Bridge-to-transplant and Destination Therapy (CAG-00453N)","author":"Centers for Medicare and Medicaid Services","year":"2020","unstructured":"Centers for Medicare and Medicaid Services. Decision Memo for Artificial Hearts and Related Devices, Including Ventricular Assist Devices for Bridge-to-transplant and Destination Therapy (CAG-00453N) 1\u201347 (Department of Health and Human Services, 2020)."},{"issue":"10","key":"46901_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.hrcr.2020.06.029","volume":"6","author":"JE Payne","year":"2020","unstructured":"Payne, J. E. et al. Pigment nephropathy associated with percutaneous hemodynamic support during ventricular tachycardia ablation. HeartRhythm Case Rep. 6(10), 720\u2013723. https:\/\/doi.org\/10.1016\/j.hrcr.2020.06.029 (2020).","journal-title":"HeartRhythm Case Rep."},{"key":"46901_CR24","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.2215\/CJN.12731211","volume":"7","author":"DJ Askenazi","year":"2012","unstructured":"Askenazi, D. J. et al. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin. J. Am. Soc. Nephrol. 7, 1328\u20131336. https:\/\/doi.org\/10.2215\/CJN.12731211 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"46901_CR25","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/CCM.0000000000000128","volume":"42","author":"S Lou","year":"2014","unstructured":"Lou, S., MacLaren, G., Best, D., Delzoppo, C. & Butt, W. Hemolysis in pediatric patients receiving centrifugal-pump extracorporeal membrane oxygenation: Prevalence, risk factors, and outcomes. Crit. Care Med. 42, 1213\u20131220. https:\/\/doi.org\/10.1097\/CCM.0000000000000128 (2014).","journal-title":"Crit. Care Med."},{"issue":"10","key":"46901_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.hrcr.2020.06.029","volume":"6","author":"JE Payne","year":"2020","unstructured":"Payne, J. E., Hodskins, E., Gold, M. R. & Winterfield, J. Pigment nephropathy associated with percutaneous hemodynamic support during ventricular tachycardia ablation. HeartRhythm Case Rep. 6(10), 720\u2013723. https:\/\/doi.org\/10.1016\/j.hrcr.2020.06.029 (2020).","journal-title":"HeartRhythm Case Rep."},{"issue":"12","key":"46901_CR27","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1097\/MAT.0000000000001712","volume":"68","author":"I Salas de Armas","year":"2022","unstructured":"Salas de Armas, I. et al. Surgically implanted impella device for patients on impella CP support experiencing refractory hemolysis. ASAIO J. 68(12), e251\u2013e255. https:\/\/doi.org\/10.1097\/MAT.0000000000001712 (2022).","journal-title":"ASAIO J."},{"issue":"Supplement 2","key":"46901_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/01.mat.0000841208.11864.3b","volume":"68","author":"J-M Jang","year":"2022","unstructured":"Jang, J.-M. et al. REN3: Percutaneous axillary temporary mechanical support improves renal function prior to heart transplantation in patients with chronic kidney disease. ASAIO J. 68(Supplement 2), 89. https:\/\/doi.org\/10.1097\/01.mat.0000841208.11864.3b (2022).","journal-title":"ASAIO J."},{"issue":"5","key":"46901_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.26599\/1671-5411.2023.05.002","volume":"20","author":"S Paghdar","year":"2023","unstructured":"Paghdar, S. et al. One-year survival in recipients older than 50 bridged to heart transplant with Impella 5.5 via axillary approach. J. Geriatr. Cardiol. 20(5), 319\u2013329. https:\/\/doi.org\/10.26599\/1671-5411.2023.05.002 (2023).","journal-title":"J. Geriatr. Cardiol."},{"issue":"4","key":"46901_CR30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.healun.2023.02.813","volume":"42","author":"S Desai","year":"2023","unstructured":"Desai, S. et al. Systemic effects of Impella 5.5 purge solution in patients with heart failure cardiogenic shock. J. Heart Lung Transplant. 42(4), 813. https:\/\/doi.org\/10.1016\/j.healun.2023.02.813 (2023).","journal-title":"J. Heart Lung Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46901-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46901-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46901-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T15:01:46Z","timestamp":1699714906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46901-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46901"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46901-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,11]]},"assertion":[{"value":"19 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RG is a speaker for Abiomed but does not receive financial research support.  All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19671"}}